Agreement of single- and multi-frequency bioimpedance measurements in hemodialysis patients: an ancillary study of the Frequent Hemodialysis Network Daily Trial [0.03%]
血液透析患者单频和多频生物阻抗测量的一致性：每日试验的辅助研究项目(来自肾脏病流行病学合作肾移植数据注册处)
Jochen G Raimann,Samer R Abbas,Li Liu et al.
Jochen G Raimann et al.
Background: Bioimpedance analysis (BIA) is well established to assess body composition. Agreements between single- and multi-frequency bioimpedance (SF-BIA, MF-BIS) measurements in subjects undergoing 6 or 3 times/week he...
Randomized Controlled Trial
Nephron. Clinical practice. 2014;128(1-2):115-26. DOI:10.1159/000366447 2014
Leon G Fine
Leon G Fine
Shabnam Salimi,Nawi Ng,Stephen L Seliger et al.
Shabnam Salimi et al.
Background: Leukocytosis is a powerful predictor of incident chronic kidney disease (CKD) and related outcomes. However, the association between periodontitis measures and increased leukocytosis in the context of CKD has ...
Alexandre Karras,David Jayne
Alexandre Karras
The major advances achieved in immunology and cellular biology have led to the development of biotherapies that specifically target different mediators and pathways involved in the physiopathology of renal diseases. After the major breakthr...
Andrew S Bomback
Andrew S Bomback
A major shift in our understanding of the membranoproliferative glomerulonephritis (MPGN) lesion is the focus on which components of the complement pathway are involved in mediating renal injury. Hence, MPGN is no longer classified solely b...
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis [0.03%]
成人微小病变病和局灶节段性肾小球硬化症的利妥昔单抗治疗
Andreas Kronbichler,Annette Bruchfeld
Andreas Kronbichler
Treatment of nephrotic syndrome due to minimal change disease and focal segmental glomerulosclerosis remains a challenge since steroid dependence, steroid resistance and a relapsing disease course exhibits a high cumulative steroid dosage. ...
Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy [0.03%]
抗磷脂酶A2受体抗体与膜性肾病发病机制的关系
Pierre Ronco,Hanna Debiec
Pierre Ronco
Since the early 2000s, considerable advances have been achieved in the understanding of molecular pathomechanisms of human membranous nephropathy (MN), inspired by studies of Heymann nephritis, a faithful experimental model. These studies l...
Helen J Jefferies,Lisa E Crowley,Laura E A Harrison et al.
Helen J Jefferies et al.
Background/aims: Endotoxaemia, a driver of systemic inflammation, appears to be driven by dialysis-induced circulatory stress in haemodialysis (HD) patients. More frequent HD regimens are associated with lower ultrafiltra...
Observational Study
Nephron. Clinical practice. 2014;128(1-2):141-6. DOI:10.1159/000366519 2014
Frédéric A Houssiau
Frédéric A Houssiau
This position paper critically analyzes the available controlled data regarding biologic therapy in lupus nephritis (LN). Rather than an exhaustive review of all published evidence, the stress is put on the unmet medical needs in LN, the de...
Yujuan Liu,Hans-Joachim Anders
Yujuan Liu
Background/aims: Lupus nephritis is an organ manifestation of systemic autoimmunity. Current treatment algorithms are still based on unselective immunosuppressive drugs. There is hope that highly selective biological drug...